New drug aims to tame lupus and Sjogren's by targeting immune cells

NCT ID NCT06977724

First seen Oct 31, 2025 · Last updated May 04, 2026 · Updated 24 times

Summary

This early-stage trial tests an investigational drug called ABBV-319 in about 36 adults with lupus or Sjogren's disease. The drug works by depleting certain immune cells (B cells) that are overactive in these conditions. The main goals are to check the drug's safety, how it moves through the body, and its effects on symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Amsterdam UMC, locatie AMC /ID# 274286

    RECRUITING

    Amsterdam, North Holland, 1105 AZ, Netherlands

  • Clinical Research Of West Florida - Tampa - North Howard Avenue /ID# 275836

    RECRUITING

    Tampa, Florida, 33606, United States

  • Integrative Rheumatology of South Texas - Harlingen /ID# 276458

    RECRUITING

    Harlingen, Texas, 78550, United States

    Contact Phone: •••-•••-••••

  • Life Clinical Trials /ID# 276050

    RECRUITING

    Margate, Florida, 33063, United States

  • Private Practice - Dr. Ramesh C. Gupta I /ID# 275826

    RECRUITING

    Memphis, Tennessee, 38119, United States

    Contact Phone: •••-•••-••••

  • Universitair Medisch Centrum Utrecht /ID# 273398

    RECRUITING

    Utrecht, 3584 CX, Netherlands

Conditions

Explore the condition pages connected to this study.